The global CIDP market is fueled by technological advancements, including novel diagnostic imaging and targeted drug delivery systems. These innovations enable faster diagnosis, improved disease management, and better long-term patient outcomes. https://www.marketresearchfuture.com/reports/chronic-inflammatory-demyelinating-polyneuropathy-market-6947